原发性肝癌切除术后的抗复发治疗附视频

被引：9

作者：

阎振林

李俊

沈锋

机构：

[1] 第二军医大学附属东方肝胆外科医院

来源：

肝胆胰外科杂志 | 2009年 / 04期

关键词：

肝肿瘤; 外科手术; 复发; 治疗;

D O I：

暂无

中图分类号：

R735.7 [肝肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

<正>原发性肝癌(简称肝癌)主要指肝细胞癌(hepa-tocellular carcinoma,HCC),是居我国第二位的肿瘤死亡原因。目前肝切除术及肝移植术仍是可治愈肝癌的唯一手段。但是,限于供体来源及经济条件,肝

引用

页码：253 / 256

页数：4

共 19 条

[1]

Hepatocellular carcinoma: current management and recent advances[J] Wan-Yee Lau;Eric C. H. Lai; Hepatobiliary & Pancreatic Diseases International 2008, 03

[2]

Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma[J] Soocheol Jeong;Hiroshi Aikata;Yoshio Katamura;Takahiro Azakami;Tomokazu Kawaoka;Hiromi Saneto;Kiminori Uka;Nami Mori;Shintaro Takaki;Hideaki Kodama;Koji Waki;Michio Imamura;Hiroo Shirakawa;Yoshiiku Kawakami;Shoichi Takahashi;Kazuaki Chayama; World Journal of Gastroenterology 2007,

[3]

术后经导管动脉化疗栓塞对不同病理特征肝癌的抗复发作用[J] 奚韬;闫振林;王葵;李俊;夏勇;沈锋;吴孟超; 中华外科杂志 2007, 09

[4]

Implantation of a drug delivery system during surgery for patients with primary hepatocarcinoma [J].

WanPing Chen Xin He QiFa Ye and Ke Li Institute of Organ Transplantation Third Xiangya Hospital Xiangya Medical College Central South University Changsha China and Institute of Clinical Pharmacology Xiangya Medical College Central South University Changsha China .

Hepatobiliary&PancreaticDiseasesInternational, 2006, (03) :391-395

[5]

Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis [J].

Jun Wen WenLv Shen and ShaoHua Yang Department of Surgery Second Hospital of Shantou University of Medical College Shantou China .

Hepatobiliary & Pancreatic Diseases International, 2006, (02) :224-227

[6]

肝动脉插管化疗栓塞在预防肝癌术后复发中的应用价值 [J].

程红岩 ;

徐雯 ;

徐爱民 ;

陈栋 ;

杨业发 ;

贾雨辰 .

中华肿瘤杂志, 2005, (10) :626-628

[7]

α干扰素和卡培他滨对肝癌根治性切除术后转移复发抑制作用的实验研究 [J].

潘烨 ;

郑起 ;

艾开兴 ;

闫钧 ;

薛琼 .

肿瘤, 2005, (05)

[8]

Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor:A retrospective control study[J] Zheng-Gang Ren Zhi-Ying Lin Jing-Lin Xia Sheng-Long Ye Zeng-Chen Ma Qing-Hai Ye Lun-Xiu Qin Zhi-Quan Wu Jia Fan Zhao-You Tang Liver Cancer Institute and Zhongshan Hospital;Fudan University;Shanghai 200032;China World Journal of Gastroenterology 2004,

[9]

肝癌特异性细胞毒 T 淋巴细胞的实验及临床研究[J] 沈锋;王皓;谢天培;施乐华;钱卫珠;刘新垣;吴孟超;郭亚军中华外科杂志 1997, 02

[10]

Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation[J] Zheng-Hua Lu;Feng Shen;Zhen-Lin Yan;Jun Li;Jia-He Yang;Ming Zong;Le-Hua Shi;Meng-Chao Wu Journal of Cancer Research and Clinical Oncology 2009,

← 1 2 →